Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid x receptor‐dependent inhibition of hepatic stellate cell contraction
Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid x receptor‐dependent inhibition of hepatic stellate cell contraction
Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid x receptor‐dependent inhibition of hepatic stellate cell contraction
Xu, Wenxuan (Autor:in) / Lu, Chunfeng (Autor:in) / Zhang, Feng (Autor:in) / Shao, Jiangjuan (Autor:in) / Yao, Shunyu (Autor:in) / Zheng, Shizhong (Autor:in)
FEBS JOURNAL ; 284 ; 114-133
01.01.2017
20 pages
Aufsatz (Zeitschrift)
Englisch
DDC:
572
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Wiley | 2019
|TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis
BASE | 2017
|TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis
BASE | 2018
|Wiley | 2025
|CD9 Counteracts Liver Steatosis and Mediates GCGR Agonist Hepatic Effects
Wiley | 2024
|